期刊文献+

双歧杆菌三联活菌联合5-氨基水杨酸治疗溃疡性结肠炎的临床观察

The effects of double branch bacilli triplex viable bacteria combined with 5-aminosalicylic acid on ulcerative colitis and the serum levels of IL-1 and IL-4
下载PDF
导出
摘要 目的:探讨双歧杆菌三联活菌联合5-氨基水杨酸对溃疡性结肠炎(UC)的临床疗效以及对血清白细胞介素-1(IL-1)和IL-4的影响。方法:将77例UC患者随机分为5-氨基水杨酸组38例(对照组)和5-氨基水杨酸联合双歧杆菌三联活菌治疗组39例(观察组);治疗6周后,观察临床症状改变以及治疗前后两组血清中IL-1和IL-4的表达变化。结果:观察组总有效率高于改善情况明显优于对照组,表现为腹痛、腹泻、黏液脓血便症状好转或消失。观察组患者血清IL-1降低水平、血清IL-4升高水平与对照组(P<0.05),血清IL-4升高水平较对照组升高明显(P<0.05)。结论:双歧杆菌三联活菌联合5-氨基水杨酸治疗UC疗效肯定,同时双歧三联活菌有助于逆转Th1和Th2细胞的失衡状态。 Objective:To explore the effects of double branch bacilli triplex viable bacteria combined with 5-amino acid on ulcerative colitis(UC) and the serum levels of IL-1 and IL-4. Methods:Seventy-seven cases with UC were randomly divided into 5-aminosalicylic acid group(control group,38 cases) and 5-aminosalicylic acid combined with double branch bacilli triplex viable bacteria group(observation group,39 cases).The clinical symptoms and the serum levels of IL-1 and IL-4 were evaluated at 6 weeks after treatment. Results:Compared with the control group,the clinical symptoms of observation group were significantly improved(P0.05),and serum levels of IL-1 and IL-4 significantly decreased and increased(P0.05). Conclusions:The effects of double branch bacilli triplex viable bacteria combined with 5-aminosalicylic acid on UC are good,can adjust the imbalance of Th1/Th2 cells.
出处 《蚌埠医学院学报》 CAS 2012年第5期567-569,共3页 Journal of Bengbu Medical College
关键词 溃疡性结肠炎 白细胞介素-1 白细胞介素-4 双歧杆菌三联活菌 5-氨基水杨酸 ulcerative colitis interleukin-1 interleukin-4 5-aminosalicylic acid double branch bacilli triplex viable bacteria
  • 相关文献

参考文献1

二级参考文献15

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.
  • 4欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84.
  • 5Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413.
  • 6Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753.
  • 7Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75.
  • 8Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643.
  • 9Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut, 2006, 55 Suppl 1:i1- i15.
  • 10Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut, 2004, 53 Suppl 5: Ⅴ1-Ⅴ16.

共引文献1021

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部